Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Physician Knowledge of Key Safety Information for Eylea in Canada: An Observational Postauthorization Safety Study

NCT02585401 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02585401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02585401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Physician Knowledge of Key Safety Information for Eylea in Canada: An Observational Postauthorization Safety Study
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
February 18, 2016
Completion date
May 19, 2016
Enrollment
99 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration (amd), central retinal vein occlusion (crvo), diabetic macular edema (dme)